Colgate-Palmolive Company Financial Statements (CL)
|
|
|
|
Report date
|
|
|
17.02.2022 |
16.02.2023 |
15.02.2024 |
13.02.2025 |
23.02.2026 |
|
31.03.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
17 421 |
17 967 |
19 457 |
20 101 |
20 382 |
|
20 795 |
|
Operating Income, bln rub |
|
|
3 886 |
3 585 |
4 131 |
4 383 |
4 348 |
|
4 410 |
|
EBITDA, bln rub |
? |
|
3 760 |
3 372 |
4 246 |
4 853 |
3 956 |
|
3 917 |
|
Net profit, bln rub |
? |
|
2 166 |
1 785 |
2 300 |
2 889 |
2 132 |
|
2 087 |
|
|
OCF, bln rub |
? |
|
3 325 |
2 556 |
3 745 |
4 107 |
4 198 |
|
4 345 |
|
CAPEX, bln rub |
? |
|
567.0 |
696.0 |
705.0 |
561.0 |
564.0 |
|
578.0 |
|
FCF, bln rub |
? |
|
2 758 |
1 860 |
3 040 |
3 546 |
3 634 |
|
3 767 |
|
Dividend payout, bln rub
|
|
|
1 679 |
1 691 |
1 749 |
1 789 |
1 823 |
|
1 834 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
|
|
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
77.5% |
94.7% |
76.0% |
61.9% |
85.5% |
|
87.9% |
|
|
OPEX, bln rub |
|
|
6 407 |
6 565 |
7 120 |
7 723 |
7 903 |
|
8 086 |
|
Cost of production, bln rub |
|
|
7 128 |
7 817 |
8 206 |
7 995 |
8 131 |
|
8 305 |
|
R&D, bln rub |
|
|
307.0 |
320.0 |
343.0 |
355.0 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
117.0 |
167.0 |
287.0 |
292.0 |
267.0 |
|
264.0 |
|
|
Assets, bln rub |
|
|
15 040 |
15 731 |
16 393 |
16 046 |
16 330 |
|
16 610 |
|
Net Assets, bln rub |
? |
|
609.0 |
401.0 |
609.0 |
212.0 |
54.0 |
|
145.0 |
|
Debt, bln rub |
|
|
7 833 |
9 271 |
9 064 |
8 512 |
7 988 |
|
7 973 |
|
Cash, bln rub |
|
|
832.0 |
775.0 |
966.0 |
1 256 |
1 288 |
|
1 419 |
|
Net debt, bln rub |
|
|
7 001 |
8 496 |
8 098 |
7 256 |
6 700 |
|
6 554 |
|
|
Ordinary share price, rub |
|
|
85.3 |
|
|
90.9 |
79.0 |
|
88.0 |
|
Number of ordinary shares, mln |
|
|
845.0 |
836.4 |
827.4 |
817.7 |
808.7 |
|
802.3 |
|
|
Market cap, bln rub |
|
|
72 112 |
0 |
0 |
74 337 |
63 903 |
|
70 634 |
|
EV, bln rub |
? |
|
79 113 |
8 496 |
8 098 |
81 593 |
70 603 |
|
77 188 |
|
Book value, bln rub |
|
|
-5 137 |
-4 871 |
-4 688 |
-4 816 |
-4 604 |
|
-4 483 |
|
|
EPS, rub |
? |
|
2.56 |
2.13 |
2.78 |
3.53 |
2.64 |
|
2.60 |
|
FCF/share, rub |
|
|
3.26 |
2.22 |
3.67 |
4.34 |
4.49 |
|
4.70 |
|
BV/share, rub |
|
|
-6.08 |
-5.82 |
-5.67 |
-5.89 |
-5.69 |
|
-5.59 |
|
|
EBITDA margin, % |
? |
|
21.6% |
18.8% |
21.8% |
24.1% |
19.4% |
|
18.8% |
|
Net margin, % |
? |
|
12.4% |
9.93% |
11.8% |
14.4% |
10.5% |
|
10.0% |
|
FCF yield, % |
? |
|
3.82% |
|
|
4.77% |
5.69% |
|
5.33% |
|
ROE, % |
? |
|
355.7% |
445.1% |
377.7% |
1 363% |
3 948% |
|
1 439% |
|
ROA, % |
? |
|
14.4% |
11.3% |
14.0% |
18.0% |
13.1% |
|
12.6% |
|
|
P/E |
? |
|
33.3 |
0.00 |
0.00 |
25.7 |
30.0 |
|
33.8 |
|
P/FCF |
|
|
26.1 |
0.00 |
0.00 |
21.0 |
17.6 |
|
18.8 |
|
P/S |
? |
|
4.14 |
0.00 |
0.00 |
3.70 |
3.14 |
|
3.40 |
|
P/BV |
? |
|
-14.0 |
0.00 |
0.00 |
-15.4 |
-13.9 |
|
-15.8 |
|
EV/EBITDA |
? |
|
21.0 |
2.52 |
1.91 |
16.8 |
17.8 |
|
19.7 |
|
Debt/EBITDA |
|
|
1.86 |
2.52 |
1.91 |
1.50 |
1.69 |
|
1.67 |
|
|
R&D/CAPEX, % |
|
|
54.1% |
46.0% |
48.7% |
63.3% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
3.25% |
3.87% |
3.62% |
2.79% |
2.77% |
|
2.78% |
|
| Colgate-Palmolive Company shareholders |
